Clinical Trials Logo

Filter by:
NCT ID: NCT05480618 Enrolling by invitation - Clinical trials for Spinal Cord Injuries

Slow Yogic-Derived Breathing and Respiration and Cardiovascular Variability in Spinal Cord Injury Patients

SCOGA
Start date: August 22, 2022
Phase: N/A
Study type: Interventional

This research will aid in understanding of slow-breathing and its effect on heart rate and blood pressure in people with a spinal cord injury (SCI). This research will investigate if traditional 'yogic' breathing exercises can be performed by subjects with SCI and its influence on the cardiovascular system.

NCT ID: NCT05477862 Enrolling by invitation - Alzheimer Disease Clinical Trials

Neural Mechanisms of Clinically Designed Improvisatory Music for Alzheimer's Disease

Start date: October 15, 2023
Phase: N/A
Study type: Interventional

Clinically Designed Improvisatory Music (CDIM) is a form of improvised music based on calm-inducing sound parameters which brought relief to our cohort of neurology patients. As a direct sound-based approach, CDIM does not rely on autobiographical memory and may have wider applicability and generalizability. We wish to examine if CDIM decreases anxiety in 15 cognitively healthy individuals and 15 Alzheimer Disease patients with anxiety (AD-A).

NCT ID: NCT05477485 Enrolling by invitation - Clinical trials for Human Immunodeficiency Virus

Antiretroviral Improvement Among Medicaid Enrollees

AIMS
Start date: April 27, 2023
Phase: N/A
Study type: Interventional

This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.

NCT ID: NCT05477004 Enrolling by invitation - Chronic Pain Clinical Trials

Observational Study of Ketamine Infusions for the Treatment of Chronic Pain

Start date: June 1, 2022
Phase:
Study type: Observational

This observational study will collect prospectively specified data on patient characteristics and clinically relevant outcomes in patients who receive a ketamine infusion at Stanford Pain Management Center for the treatment of chronic pain, with the goal of identifying treatment responders and relationships between patient characteristics and treatment response.

NCT ID: NCT05474274 Enrolling by invitation - Pain Clinical Trials

PAIN (Pain AI iNtervention) Platform for Patients at Home

Start date: November 23, 2022
Phase:
Study type: Observational

The purpose of this research is to identify physiological markers to determine pain intensity and build an Artificial Intelligence (AI) enabled system to objectively measure pain intensity. Researchers hope to personalize pain medication regimens to help prevent medication over-use.

NCT ID: NCT05474027 Enrolling by invitation - Clinical trials for Blood Loss, Surgical

Reducing Hypotensive Anesthesia Use With TXA During Orthognathic Surgery

Start date: November 11, 2022
Phase: Phase 4
Study type: Interventional

This prospective study will analyze the need for deliberate hypotensive anesthesia (DHA) during orthognathic surgery when tranexamic acid (TXA) is administered. DHA has been proven to be effective although it comes with multiple risks related to organ hypoperfusion including kidney injury, stroke, and cardiac ischemia. Therefore, it may be potentially safer for patients to avoid deliberate hypotensive anesthesia if TXA alone adequately controls blood loss and provides adequate surgical site visualization.

NCT ID: NCT05472649 Enrolling by invitation - Long-term Follow-up Clinical Trials

Long-Term Follow-Up of Patients Who Received Gene-Modified Cell Therapy

Start date: June 16, 2021
Phase:
Study type: Observational

Observational long-term follow-up study of patients who have been exposed to a gene-modified cell therapy produced by ex vivo transduction of immune cells expressing viral or non-viral vectors in studies sponsored by Sorrento Therapeutics, Inc.

NCT ID: NCT05472597 Enrolling by invitation - Clinical trials for Cardiovascular Diseases

Continuation of the nuMoM2b Heart Health Study

nuMoM2b-HHS2
Start date: November 29, 2022
Phase:
Study type: Observational

Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in U.S. women at all ages, and large knowledge gaps exist in CVD predictive and preventative strategies for women. The nuMoM2b Heart Health Study (nuMoM2b-HHS) has followed a demographically diverse cohort of women enrolled and richly phenotyped during their first pregnancy, with data and biospecimens prospectively collected for up to 7 years thereafter. The overarching scientific goal of this study is to define the relationship between adverse pregnancy outcomes (APOs) and CVD to optimize CVD prediction, prevention, and treatment strategies for women. Continued follow-up of this observational cohort, building on a foundation of existing high-quality data, biospecimens, and administrative structures with a robust framework for ancillary study development and implementation, provides a unique opportunity to address knowledge gaps regarding the early mechanisms and trajectory of CVD in women.

NCT ID: NCT05470257 Enrolling by invitation - Clinical trials for Fracture of Radius and Ulna

Randomized Control Trial: Elbow Extension Versus Flexion Cast in Proximal Half Both Bone Forearm Fractures

Start date: April 7, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to compare outcomes between two immobilization methods for pediatric proximal half both bone forearm fractures.

NCT ID: NCT05468463 Enrolling by invitation - Kidney Diseases Clinical Trials

Promoting Increases in Living Donation Via Tele-navigation (PILOT)

PILOT
Start date: April 12, 2023
Phase: N/A
Study type: Interventional

We hypothesize that expansion of the Living Donor Navigator (LDN) program to include tele-health delivery will overcome geographic disparities in access and facilitate sustained increases in living donation. We will utilize an individually randomized group trial (IRGT) design with delayed intervention initiation to compare the effectiveness of tele-health LDN model to standard of care.